Introducing the Creyos Cognitive Screen, Test, and Care Plan

In this session, experts Faraz Shafaghi and Mike Battista will demonstrate and describe the science behind our latest cognitive care protocol.

The early signs of dementia, such as mild cognitive impairment (MCI) often go unrecognized and, as a result, care that could help improve patient quality of life is delayed. We designed this tool to help physicians close the gap in testing and care planning, all while potentially growing their practice, improving administrative efficiencies, and delivering a better patient experience.